Alston Chiu

Queen Mary Hospital. HeartTeam. @HongKongValves

[JACC Journals @JACCJournals]

UNICORN during #TAVR was successful in preventing coronary obstruction. Intraprocedural hypotension requiring vasopressor support was frequent. UNICORN should be considered in cases in which lower risk options are unlikely to be successful. https://t.co/k03fGqkEHW #JACCINT

[Alston Chiu @ChiuAlston]

@GilbertTangMD Grateful to be part of this project, and continue pursuing best practice in leaflet modification in the era facing the surge of ViV-TAVR and redo TAVR.

#Leafletmodificafion #JACCINT @JACCJournals #BASILICA #UNICORN #LAMPOON #BATMAN

[Alston Chiu @ChiuAlston]

@GilbertTangMD @JACCJournals Grateful to be part of this project, and continue pursuing best practice in leaflet modification in the era facing the surge of ViV-TAVR and redo TAVR.

#Leafletmodificafion #JACCINT @JACCJournals #BASILICA #UNICORN #LAMPOON #BATMAN

[Dr. Gilbert Tang @GilbertTangMD]

Proud to have helped curate the 2-part landmark special issue on LEAFLET MODIFICATION (LM) in #JACCINT @JACCJournals with Editor-in-Chief David Moliterno and Vasilis Babaliaros to celebrate the 10-anniversary of the 1st leaflet modification done in the world (LAMPOON)! Grateful to be a senior author and co-author of several papers.
https://t.co/BfuHHMYn6B
https://t.co/opVuDDe44D

Congrats to all the authors from around the world who have contributed to this seminal effort!

Key highlights:
Leaflet modification algorithms:
https://t.co/CnBv8MP8js

AORTIC Leaflet Modification
BASILICA step-by-step review:
https://t.co/LTKQA9kLpL
UNICORN step-by-step review:
https://t.co/xvLJhnqVkg
"Split-line" Concept in LM in Redo-TAVR:
https://t.co/jmonmoxsuE
UNICORN benchtop validation in redo-TAVR: works better with failed Sapien, Evolut, Acurate than Navitor:
https://t.co/mLX8u0iEmI
UNICORN registry:
https://t.co/Xz1eWwpiKZ
Bench testing showing UNICORN more effective than (BA)BASILICA in Redo-TAVR:
https://t.co/snsi2oMtPI
Bench testing showing LM in redo-TAVR dependent on TAV type, constraint, 2nd TAV implant. BASILICA no effect on Navitor and BA-BASILICA better with failed Evolut + Acurate
https://t.co/p6LBcvQ6jV
HALT reduction with leaflet modification in VIV #TAVR:
https://t.co/RkqkHRBdv4
Bench testing on LM of calcified native and SAV leaflets showed higher Ca burden increased laceration difficulty, leaflet tears and embolic debris; less spray with shorter leaflet length
https://t.co/2jjGfol5c0
LOFTER-TAVR registry:
https://t.co/nYrXz5NZAa
CT simulation of LM impact on Redo-TAVR Feasibility:
https://t.co/1s4zmf15uv
Fluoro Left-Main Frame Alignment View to Evaluate coronary obstruction in redo-TAVR:
https://t.co/RplVZPEQxY
FIH wire anchoring-assisted BASILICA/UNICORN:
https://t.co/NjzGYtFyuY
FIH tricupsidization of bicuspid native #TAVR
https://t.co/P3HZIDRSFP

Mitral Leaflet Modification
LAMPOON/BATMAN step-by-step:
https://t.co/1gtedQXmP8
BATMAN registry
https://t.co/30rWokpCE2
TRICUSPID Leaflet Modification
ELASTA-T for failed T-TEER to facilitate TTVR step-by-step:
https://t.co/0TIECD3yus

Mechanisms of failed BASILICA/LAMPOON/SEASAME:
https://t.co/oqH9okmTPw

[Atsushi Kikuchi @ak_cardiol]

Our first Tricuspid TEER case !!
今週4例の重症TR症例を治療させていただきました。
全てsevere → mild以下で期待以上の仕上がり👏
久々の新規SHD治療で緊張しましたが、いい治療だと思います🤝

[Dr. Gilbert Tang @GilbertTangMD]

JUST OUT #JACCCaseReports @JACCJournals on CALL FOR PAPERS for FONTAN patients, led by our Guest Editor In Chief and Associate Editor @achdoctmoe . Send your submission to us by JUNE 24!

https://t.co/JZHp20M3U7

@MinnowWalsh
@Justine_Turco
@hmkyale
@chrissymd2000 @jsaef1

[HongKongValves @HongKongValves]

💫✨⚡️Hong Kong Valves 10th Anniversary - Electrosurgery Classroom ⚡️✨💫

Join Electrosurgery Classroom at Hong Kong Valves 2026 this year - 16th-18th October 2026!

Register now at https://t.co/YOV9kZnPVR

We are calling for submissions! Submit your challenging cases and scientific abstracts. Don’t miss this chance to present your work! Scientific Abstracts and Challenging Case Submission deadline: 30th April 2026

Challenging Case Submission: https://t.co/zfHdY19QkW
Scientific Abstract Submission: https://t.co/mqjrpobfOX

#HongKongValves2026 #10thanniversary #HongKongValves10thAnniversary #APEelectrosurgeryclassroom #callingforsubmission

[Alston Chiu @ChiuAlston]

@summitmd_cvrf @HiteshiKc Join Seoul Valves 2026!

[summitmd_cvrf @summitmd_cvrf]

At #SEOULVALVES2026, your case gets heard by those leading the future of 𝗩𝗮𝗹𝘃𝘂𝗹𝗮𝗿 and 𝗦𝘁𝗿𝘂𝗰𝘁𝘂𝗿𝗮𝗹 𝗛𝗲𝗮𝗿𝘁 intervention. Submit your work now and bring it to a stage where the world's leaders are listening!

🔗Submit My Case: https://t.co/tznYKUy53I

[Miho.Fukui @Miho_Fukui_]

Update on Aortic ViV App! Check it out, now BRAILE Valves are available on the App @bapat_savrtavr @MHIF_Heart #ViV #Valve-in-Valve

[Dr. Gilbert Tang @GilbertTangMD]

#WorldCup2026 is coming soon! DO NOT FORGET to submit to #JACCCaseReports @JACCJournals on our Special CALL FOR PAPERS for this issue to be published the week of the FINALS in mid-July. Anything round or spherical, or team-based submissions will be considered. Deadline is today but we will extend it for another week!

https://t.co/XmpvyoGiIO

@hmkyale
@Justine_Turco
@MinnowWalsh @aroniskn @JACabreraCardio @MiChen__ @aabha_divya @sarano_maurice @Miho_Fukui_ @ErikaHuttce @Nishaki1 @ChrissyMD2000 @ACHDocTMoe @PanjrathG @M_Pompeu_Sa_MD @jsaef1 @JTSaxon @Kentso987 @TagliariPaula @m_taramasso @SyedZaidMD

[Dr. Gilbert Tang @GilbertTangMD]

Thank you @TCTMD and @TCTMD_Yael for interviewing me on the #ACC26 #TRISCEND2 #Evoque #TTVR data and how to put it into context of T-TEER vs TTVR in transcatheter tricuspid valve therapy for symptomatic severe TR
@MountSinaiHeart
@MountSinaiNYC
@IcahnMountSinai
@Dr_BrendanCarr
@DrDavidReich

https://t.co/O340V8Uh1J

[Dr. Gilbert Tang @GilbertTangMD]

Congrats and please welcome our newest Associate Editor @JACCJournals #JACCCaseReports @karlkpoon from Brisbane, Australia, specializing in coronary and structural interventions (and many firsts in the region), further expanding our global footprint of this multidisciplinary, multidimensional journal to APAC and ANZ region, beyond just case reports, but becoming an international educational platform for all cardiovascular communities.

@MinnowWalsh
@hmkyale
@Justine_Turco
@NAkhterMD @aroniskn @JACabreraCardio @MiChen__ @aabha_divya @sarano_maurice @Miho_Fukui_ @ErikaHuttce @Nishaki1 @ChrissyMD2000 @ACHDocTMoe @PanjrathG @M_Pompeu_Sa_MD @jsaef1 @JTSaxon @Kentso987 @TagliariPaula @m_taramasso @SyedZaidMD

[Sara Moscatelli @saramoscatelli7]

🫀 SPORTS CARDIOLOGY: what every cardiologist should know
New review just out 👉
Exercise is medicine… but not always harmless.

⚠️ Key message:
Sudden cardiac death (SCD) in athletes is rare (~1:50,000) but often the first manifestation of underlying disease
🔍 What really matters in practice?

1. Screening works (but not perfectly)
✔️ ECG-based screening can reduce SCD by up to 90%
❗ Still misses ~20% of conditions (e.g. coronary disease, fibrosis)

2. Athlete’s heart ≠ cardiomyopathy
The biggest challenge is NOT finding disease…
👉 it’s not overcalling disease
Physiological adaptations can mimic:
HCM
DCM
ARVC
LV non-compaction
➡️ Requires multimodality approach (ECG + imaging + exercise + genetics)

3. Red flags you should never ignore 🚩
Exertional syncope
Chest pain
Family history of SCD
Abnormal ECG (TWI lateral, ST depression, Q waves)

4. CMR is your best friend
👉 Especially when ECG is abnormal
👉 Detects fibrosis and subtle cardiomyopathy
(Yes… this aligns perfectly with what we see in ACM/arrhythmogenic phenotypes 👀)

5. Exercise prescription is evolving
❌ Old approach: “stop sport”
✅ New approach: shared decision-making

Some key points:
ARVC / desmosomal variants → avoid high-intensity exercise
Low-risk HCM/DCM → may still participate
Myocarditis → no sport for ≥3 months

6. The new frontier: master athletes 🏃‍♂️
↑ atrial fibrillation (3–5x)
↑ coronary calcium
↑ myocardial fibrosis
👉 Long-term effects still unclear

🧠 Take-home message
Sports cardiology is not about restricting athletes.
It’s about:
✔️ Identifying risk
✔️ Avoiding misdiagnosis
✔️ Enabling safe exercise

💡 My reflection:
This is exactly where imaging + genetics + phenotype integration becomes critical — especially in early/arrhythmogenic cardiomyopathies.

https://t.co/bQFlrEKZnS

[Nadeen N. Faza, M.D. @NadeenFaza]

🫀#ACC26 Late-Breaking Clinical Trials — At-a-Glance Summary:

📅 Saturday, March 28
🔹 Session I (9:30–10:30 AM)

Themes: PE, AF stroke prevention, STEMI unloading

✅HI-PEITHO → Catheter-directed thrombolysis vs anticoagulation in PE
✅CHAMPION-AF → LAA closure vs anticoagulation
✅STEMI Door-to-Unload → LV unloading in anterior STEMI

🔹 Session II (3:45–4:45 PM)

Themes: Hypertension, lipids, prevention

✅Tonlamarsen (Kardinal) → uncontrolled HTN
✅VESALIUS-CV → Evolocumab in primary prevention
✅Intensive LDL lowering in ASCVD
✅GoFreshRx → Food-based BP intervention

📅 Sunday, March 29
🔹 Session III (8:30–9:30 AM)

Themes: PCI strategy & physiology

✅CHIP-BCIS3 → LV support in high-risk PCI
✅Angio-derived physiology vs pressure wire
✅ORBITA-CTO → CTO PCI vs placebo
✅FAST III → FFR vs QCA-derived vessel FFR

🔹 Session IV (10:45–11:45 AM)

Themes: Heart failure & pulmonary HTN

✅Spironolactone in HF
✅CADENCE → Sotatercept in HFpEF + PH
✅Lung impedance-guided therapy
✅SCOUT-HCM → Mavacamten in adolescents

🔹 Session V (4:00–5:00 PM)

Themes: Structural interventions

✅SURVIV → Redo surgery vs valve-in-valve (mitral)
✅TAVI without routine PCI
✅Embolic protection: Emboliner vs Sentinel
✅Tri-fr → Transcatheter tricuspid repair

📅 Monday, March 30
🔹 Session VI (8:30–9:30 AM)

Themes: Prevention, pharmacology, secondary prevention

✅Thrive → Food-as-medicine in HTN
✅Digoxin in rheumatic disease
✅β-blocker discontinuation post-MI
✅Olezarsen → triglycerides & plaque progression

🔹 Session VII (10:45–11:45 AM)

Themes: PCI optimization & imaging

✅SirPAD → sirolimus-coated balloon (PAD)
✅IVUS-CHIP → IVUS in high-risk PCI
✅OPTIMAL → IVUS vs angio in left main
✅IVUS vs angio in bifurcation PCI

#Cardiotwitter #ACCFIT #CardioX

[Dr. Gilbert Tang @GilbertTangMD]

JUST OUT this week #JACCINT @JACCJournals FULL OF AMAZING #TRICUSPID VALVE papers with editorials. No time to highlight each one but here're the key figures and links to the key papers: Tricuspid risk score in TTVI, PVL + RV failure in #TTVR (TRIPLACE, CESAR-TR), CT biventricular remodeling in TTVR, bleeding and ALT levels impact on T-TEER and T-TEER failure management (TriValve, FATE), clever looped lead positioning in T-TEER and FIH Gortex cuff add-on BEV to facilitate TVIR TTVR to minimize PVL. Don't miss these great contents!
FULL ISSUE:
https://t.co/eFFIoDOs4b
Key papers:
Risk score:
https://t.co/snTcqHNUVR
https://t.co/HdQeDFBaqa
TRIPLACE on PVL post TTVR:
https://t.co/hF39xs6Fci
https://t.co/LPHr2vzIae
CESAR-TR in TTVR hemodynamic instability:
https://t.co/ofEHLzUVxG
https://t.co/YphafLxHUp
Bleeding in T-TEER in TriValve registry:
https://t.co/Q804pM89C0
https://t.co/WAb7eVonBP
T-TEER failure management (FATE registry):
https://t.co/bQ2eXYgQtW
https://t.co/T47QSz198i
ALT level and outcomes in T-TEER:
https://t.co/EFnUmrimbT
CT dynamic modeling of biventricular function post TTVR:
https://t.co/nJtJyxUULT
FIH Tricuspid valve-in-ring with Gortex outflow reinforcement to minimize PVL
https://t.co/Tr9KJVJU0r
Steerable looped lead repositioning to facilitate T-TEER
https://t.co/pSMUXFzEgp

[OPCI @OPCILive]

⌛️Limited Spots Open - Don't Miss Out! OPCI Mastering Electrosurgery Workshop | May 30, NYC 🔥

Register now 👉https://t.co/9xwwuE08W4

Attend this immersive workshop where pioneers in the field will lead hands-on training to equip structural operators with the knowledge, skills, and resources to perform electrosurgical procedures with appropriate guidance. 🎯

Featuring focused sessions on:

✔️Transcaval
✔️ BASILICA
✔️ LAMPOON
✔️ UNICORN/BATMAN.

@CathElectroSurg @OKhaliqueMD #cardiotwitter #cardiox

[OPCI @OPCILive]

Don't Miss Out! Few Spots Remaining: OPCI Mastering Electrosurgery Workshop | May 30, NYC 🔥 https://t.co/BegejcngAp

🌟Limited-time offer: Complimentary registration for fellows who register with an interventionalist from their institution. First-come, first-served, based on availability.🌟

Attend this immersive workshop where pioneers in the field will lead hands-on training to equip structural operators with the knowledge, skills, and resources to perform electrosurgical procedures with appropriate guidance. Featuring focused sessions on Transcaval, BASILICA, LAMPOON, and UNICORN/BATMAN.

@CathElectroSurg @OKhaliqueMD #cardiotwitter

[Dr. Gilbert Tang @GilbertTangMD]

WOW! JUST OUT #JACCINT JACC Journals on #mechanical #valve fracture in vitro and bench study of VIV #TAVR in mechanical valves. Great editorial and insight by the #Vancouver group with #JohnGWebbMD and @sellers_steph

https://t.co/kptL0XvBMT
https://t.co/fUZRuGmHun
https://t.co/dqqM8hHnlW